Mode
Text Size
Log in / Sign up

CT-based radiomics nomogram predicts overall survival in patients with primary tracheal malignancyCT scans may help predict survival in tracheal cancer patients

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note CT-based nomogram predicts survival in primary tracheal malignancy, retrospective design limits causal inference.

This retrospective cohort study evaluated prognostic factors in a population of 115 patients with primary tracheal malignancy. The study design involved a retrospective review of available clinical and imaging data and methodology to determine survival predictors within this specific patient group.

The intervention focused on CT-based radiomics features, specifically the Radscore, combined with clinical and CT features including longitudinal length. The comparator for this analysis was longitudinal length alone. The primary outcome assessed was overall survival. Data collection occurred retrospectively.

Regarding predictive performance, the nomogram combining radiomics and clinical features achieved a C-index of 0.79 with a 95% CI of 0.69-0.88. The Radscore component alone resulted in a C-index of 0.75 with a 95% CI of 0.63-0.87. Longitudinal length alone demonstrated a C-index of 0.59 with a 95% CI of 0.47-0.70. Statistical analysis utilized C-index metrics.

Safety information was not reported for adverse events, serious adverse events, discontinuations, or tolerability. No specific limitations were listed in the provided evidence. The practice relevance indicates the CT-based nomogram could individually predict the survival outcomes of PTM patients, aiding clinical decision-making. Clinicians should note the observational design when applying these findings cautiously in clinical settings.

Follow-up duration was not reported in the study details. The absence of safety data and specific limitations requires careful consideration before clinical implementation. Future studies should address these gaps.

This study examined whether specific features from CT scans could help predict how long patients with primary tracheal malignancy would live. The team looked at data from 115 patients who had already been treated. They compared using just the length of the tumor against using a special score derived from the scan images combined with clinical details. The goal was to see if the more complex method offered better predictions for overall survival.

The analysis showed that using the combined score, called a nomogram, had a predictive performance score of 0.79. This was higher than using just the tumor length, which scored 0.59. The radiomics score alone also performed better than length alone, with a score of 0.75. These numbers suggest the combined approach might be more useful for doctors planning care.

No safety issues were reported because the study used existing medical records rather than testing a new drug or procedure. However, because this was a review of past data, the findings are not yet proven for future patients. Readers should understand that this tool could help individualize care but requires further testing to become a standard part of clinical decision-making.

What this means for you:
A new CT scan scoring method showed better survival prediction than length alone in a small past study.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
Primary tracheal malignancies (PTMs) are rare and histologically diverse, leading to complex and contentious prognostic factors. Consequently, accurately predicting the survival outcomes of these patients is challenging. This study aimed to develop a radiomics-based prognostic model for individual prediction of survival risk in PTM patients. A total of 115 patients with PTM were reviewed retrospectively and divided into the training cohort (n = 85) and validation cohort (n = 30). Radiomics features associated with overall survival (OS) were selected using the least absolute shrinkage and selection operator (LASSO) method and combined to form the radiomics score (Radscore). Multivariable analyses were used to identify clinical and CT features as independent risk factors for OS. Radscore and identified risk factors were combined to construct a radiomics nomogram. The predictive efficacy and clinical net benefit of the prognostic models were assessed using the C-index and decision curve analysis (DCA). Seven radiomics features were selected by LASSO to form a Radscore. Longitudinal length was identified as an independent prognostic factor for OS. Compared with longitudinal length (C-index: 0.59; 95% confidence interval [CI]: 0.47-0.70), both the Radscore (C-index: 0.75; 95% CI, 0.63-0.87) and nomogram (C-index: 0.79; 95% CI, 0.69-0.88) demonstrated better predictive performance and were confirmed in the validation cohort. In addition, DCA indicated that both the Radscore and nomogram provided favorable clinical net benefits. The CT-based nomogram, which combined Radscore and longitudinal length, could individually predict the survival outcomes of PTM patients, aiding clinical decision-making.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.